Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial (Q85018284)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21960168%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

editorial

0 references

title

Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21960168%20AND%20SRC:MED&resulttype=core&format=json

focal segmental glomerulosclerosis

13 February 2020

main subject

1 reference

randomized controlled trial

inferred from title

1 reference

Jeroen K J Deegens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21960168%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jack F M Wetzels

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21960168%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

0 references

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21960168%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21960168%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21960168%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

798-801

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21960168%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21960168%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2011.191

13 February 2020

exact match

0 references

cites work

Focal and segmental glomerulosclerosis: definition and relevance of a partial remission

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

Clinical trial of focal segmental glomerulosclerosis in children and young adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

Differential risk of remission and ESRD in childhood FSGS.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.191

7 January 2021

Identifiers

DOI

10.1038/KI.2011.191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21960168%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 February 2020

0 references

1 reference